Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 50%Moderate 2 · 50%High 0 · 0%

Access thrombosis/vascular complication · people receiving haemodialysis to treat kidney failure and using a functioning AV access for haemodialysis.

Scheduled surveillance showed no clear difference in risk of access thrombosis compared with clinical monitoring alone (moderate certainty).

1 finding from 1 review

Pre‐emptive correction for haemodialysis arteriovenous access stenosis 2016 · Cochrane Headline outcomes only
RR 0.95 [0.8, 1.12]
8 studies · 697 participants
Moderate

Rate of angiograms · people receiving haemodialysis to treat kidney failure and using a functioning AV access for haemodialysis.

Scheduled surveillance may leads to higher rate of angiograms compared with clinical monitoring alone (low certainty).

1 finding from 1 review

Pre‐emptive correction for haemodialysis arteriovenous access stenosis 2016 · Cochrane Headline outcomes only
RR 1.78 [1.18, 2.67]
5 studies · 539 participants
Low

Risk of access loss · people receiving haemodialysis to treat kidney failure and using a functioning AV access for haemodialysis.

Scheduled surveillance showed no clear difference in risk of access loss compared with clinical monitoring alone (moderate certainty).

1 finding from 1 review

Pre‐emptive correction for haemodialysis arteriovenous access stenosis 2016 · Cochrane Headline outcomes only
RR 0.9 [0.71, 1.15]
6 studies · 662 participants
Moderate

All‐cause mortality · people receiving haemodialysis to treat kidney failure and using a functioning AV access for haemodialysis.

Scheduled surveillance showed no clear difference in mortality compared with clinical monitoring alone (low certainty).

1 finding from 1 review

Pre‐emptive correction for haemodialysis arteriovenous access stenosis 2016 · Cochrane Headline outcomes only
RR 1.38 [0.9, 2.11]
5 studies · 586 participants
Low